Open original FDA record ↗Recall record
- FDA identifier
- Z-1728-2011
- Company in FDA record
- QIAGEN Gaithersburg, Inc.
- FDA record creation date
- Jun 26, 2015
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 17, 2026
- Recall classification
- Unknown — no matched enforcement classification
Reason stated in the source
The software component of a diagnostic medical device may be defective and could cause incorrect patient values.
Source facts
- Action
- The firm, Qiagen, sent a "Notice of Product Field Action" letter dated January 12, 2011 to all customers. The letter described the product, problem and actions to be taken. The customers were instructed to immediately discontinue the process of running multiple assay protocols on a single microplate to eliminate the potential for inaccurate patient result reporting, and to complete and return the acknowledgment section via fax to QIAGEN 661-702-3854 or scan the document and email to techservice-na@qiagen.com. The firm informed users that they will provide further detailed instructions for a workaround and software fix. A QIAGEN representative will contact the customers who indicated that they run multiple assays on a plate and are currently using the HC2 System Software Version 3.0 (Suite 4.0), to assist in the identification of those patients that may have been affected by the software defect. If you have any questions or concerns, please contact Qiagen Technical Services at 800-344-3631, Option 2.
- Initiated
- 2011-01-12
- Root cause
- Software design
- Terminated
- 2011-11-14
- Distribution
- The recalled product was sold to medical laboratories nationwide and in Canada.
- Recall number
- Z-1728-2011
- Recall status
- Terminated
- CDRH record ID
- 97490
- FDA record created
- 2015-06-26
- Recall event number
- 57814